DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Apollo Sindoori Hotels Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·13 Oct 2026, 1:53 pm

Apollo Sindoori Hotel

Apollo Sindoori Hotels Limited has informed stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance confirms that the company has fulfilled all necessary requirements for its securities to be maintained in electronic form.

For investors, this is a standard procedural update that ensures the smooth settlement of trades and the integrity of the company's shareholding structure. It is not a financial performance report but rather a confirmation of administrative compliance.

Investors should continue to focus on the company's operational metrics and market performance rather than this specific regulatory filing. This certificate is a routine administrative step and does not alter the fundamental outlook of the stock.